U S PHYSICAL THERAPY INC /NV Business Acquisition, Pro Forma Revenue
U S PHYSICAL THERAPY INC /NV (USPH) reported Business Acquisition, Pro Forma Revenue of $763.95 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-02-27
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for the quarter ending 2013-12-31 was $71.31M.
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for the quarter ending 2013-09-30 was $69.17M.
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for the quarter ending 2013-06-30 was $69.56M.
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for the quarter ending 2013-03-31 was $65.46M.
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for fiscal 2024 was $763.95M, a 12.55% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for fiscal 2023 was $678.74M.
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for fiscal 2013 was $275.51M, a 5.47% increase from fiscal 2012.
- U S PHYSICAL THERAPY INC /NV business acquisition, pro forma revenue for fiscal 2012 was $261.23M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2024-12-31 | $763.95M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $678.74M 10-K · filed 2026-02-27 | |||
| 2013-12-31 | $71.31M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $140.49M derived: sum of 2 quarters · filed 2015-03-12 | $210.05M derived: sum of 3 quarters · filed 2015-03-12 | $275.51M 10-K · filed 2015-03-12 |
| 2013-09-30 | $69.17M 10-Q · filed 2014-11-07 | $138.74M derived: sum of 2 quarters · filed 2014-11-07 | $204.20M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $69.56M 10-Q · filed 2014-08-07 | $135.02M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $65.46M 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | $261.23M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |